FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF.

Benes J, Kroupova K, Kotrc M, Petrak J, Jarolim P, Novosadova V, Kautzner J, Melenovsky V

Open source

DOI
10.1038/s41598-023-42558-4
Published
2023 Sep 25
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-023-42558-4,
  title = {FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF.},
  author = {Benes J and Kroupova K and Kotrc M and Petrak J and Jarolim P and Novosadova V and Kautzner J and Melenovsky V},
  year = {2023},
  journal = {Scientific reports},
  doi = {10.1038/s41598-023-42558-4},
  url = {https://doi.org/10.1038/s41598-023-42558-4}
}

RIS

TY  - JOUR
TI  - FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF.
AU  - Benes J
AU  - Kroupova K
AU  - Kotrc M
AU  - Petrak J
AU  - Jarolim P
AU  - Novosadova V
AU  - Kautzner J
AU  - Melenovsky V
PY  - 2023
JO  - Scientific reports
DO  - 10.1038/s41598-023-42558-4
UR  - https://doi.org/10.1038/s41598-023-42558-4
ER  - 

APA

J, B., K, K., M, K., J, P., P, J., V, N., J, K., & V, M. (2023). FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF.. Scientific reports. https://doi.org/10.1038/s41598-023-42558-4

Source records